Inside Recursion’s Pipeline: Najat Khan On AI, Data Science And Biotech Innovation

Najat Khan has built her career at the intersection of drug development and technological innovation. As chief R&D and commercial officer at Recursion, she is helping to scale one of biotech’s (or techbio’s) most ambitious efforts to industrialize drug discovery through artificial intelligence (AI).

Before joining Recursion in 2024, Khan spent over six years at Johnson & Johnson, where she served as chief data...